If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Regulatory News (TILS)

  • There is currently no data for TILS

Share Finance Facility

15 Sep 2005 08:00

ReGen Therapeutics PLC15 September 2005 ReGen Therapeutics Plc Date 15 September 2005 Committed Share Finance Facility ReGen Therapeutics Plc ("ReGen" or the "Company") announces that on 14thSeptember 2005 it entered into an agreement with the Headstart Group of funds ("Headstart") under which Headstart will make available to the Company acommitted share finance facility of up to £2,000,000 (the "Headstart Facility"). Pursuant to the terms of the Headstart Facility, Headstart has agreed, whencalled upon by the Company, to subscribe for, or purchase, new ordinary sharesin the capital of the Company ("Ordinary Shares") to the value of up to, inaggregate, £2,000,000. The Headstart Facility is available at any time up to 3years from the date a Committed Share Finance Facility Agreement is entered intoby the Company and Headstart and can be drawn down by the Company in incrementsof up to £50,000. The subscription price for an Ordinary Share shall be equalto 95% of the lowest closing bid price of an Ordinary Share in the fifteentrading days following the date on which the Company notifies Headstart that itwishes to make a draw down under the Headstart Facility. In consideration for Headstart making available the Headstart Facility, theCompany has agreed to pay Headstart a one-off underwriting commission of £60,000payable by the issue of Ordinary Shares (on the basis of an agreed value perOrdinary Share of 1.35p, being the closing bid price on Wednesday 7th September2005). £30,000 of the underwriting commission was payable upon entering into theHeadstart Facility and the remaining £30,000 is payable on the first anniversarythereafter. Accordingly, application has been made for 2,222,222 OrdinaryShares to be admitted to trading on the AIM market. It is expected thatadmission to listing will become effective and that dealings in these shareswill commence on Tuesday 20th September 2005. In addition, the Company hasagreed, subject to shareholder approval, to issue warrants granting Headstartthe right to subscribe for up to 4,000,000 Ordinary Shares at a subscriptionprice of 1.65p per share, being a price equal to 110% of the closing bid priceof the Company's shares on 13th September 2005. Such warrants will beexercisable at any time on or before 14th September 2008. As the issue of theWarrants is subject to shareholder approval, ReGen will shortly send toshareholders a circular containing a notice convening an extraordinary generalmeeting of the Company (the "Circular") for 10.00 a.m. on 10 October 2005 (the "EGM") containing resolutions to, inter alia, approve the issue of the Warrants. Copies of the Circular will be available, for collection only, free of charge tothe public, from the Company, Suite 406, Langham House, 29-30 Margaret Street,London W1W 8SA during normal office hours on any day (Saturdays, Sundaysexcepted) from 19 September 2005 until 14 October 2005. - For further information, please contact:Andrew MarshallMarshall Robinson RoeTel No 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Jul 20083:25 pmRNSSubstantial Shareholding
30th Jul 20089:51 amRNSUpdate on ADRs - Replacement
29th Jul 20081:47 pmRNSUpdate on ADRs
14th Jul 20082:30 pmRNSADRs listed on International
11th Jul 200810:51 amRNSSubstantial Shareholding
9th Jul 20084:16 pmRNSBoard Changes
26th Jun 200810:00 amRNSNew Study published
19th Jun 20085:26 pmRNSSubstantial Shareholding
17th Jun 200812:03 pmRNSResults of Zolpidem study
10th Jun 200810:12 amRNSSales Update
3rd Jun 200812:44 pmRNSResult of AGM
3rd Jun 200811:00 amRNSAGM Statement
16th May 20082:44 pmRNSShareholding
14th May 200811:23 amRNSHealthcare Conference
30th Apr 20089:13 amRNSTotal Voting Rights
28th Apr 200812:28 pmRNSAnnual Report and Accounts
25th Apr 20081:35 pmRNSScientific Review published
21st Apr 20085:43 pmRNSShareholding
17th Apr 20087:00 amRNSIssue of Equity
7th Apr 200812:14 pmRNSSubstantial Shareholding
2nd Apr 20089:00 amRNSPreliminary Results
1st Apr 20083:33 pmRNSHolding(s) in Company
31st Mar 20089:10 amRNSTotal Voting Rights
31st Mar 20088:00 amRNSResults of Study
28th Mar 20089:00 amRNSFurther Placing
26th Mar 20089:00 amRNSNew Broker and Placing
25th Mar 20083:12 pmRNSEU Import & Sale Approved
18th Mar 20089:00 amRNSChange of Registered Address
10th Mar 20087:00 amRNSEU Distributor Appointed
12th Feb 20085:59 pmRNSShareholding
11th Feb 20087:00 amRNSColostrinin Study Results
31st Jan 20083:00 pmRNSShareholding
2nd Jan 20084:53 pmRNSMajor Interest in Shares
10th Dec 20074:30 pmRNSResearch Update
6th Dec 20075:43 pmRNSSignificant Shareholding
5th Dec 20071:13 pmRNSHolding(s) in Company
5th Dec 20071:08 pmRNSHolding(s) in Company
4th Dec 200711:39 amRNSHolding(s) in Company
30th Nov 200711:30 amRNSTotal Voting Rights
22nd Nov 200711:34 amRNSHolding(s) in Company
21st Nov 20072:01 pmRNSDirector/PDMR Shareholding
20th Nov 20074:45 pmRNSResult of EGM
20th Nov 200712:08 pmRNSEGM Statement
14th Nov 20079:02 amRNSHolding(s) in Company
9th Nov 20074:06 pmRNSHolding(s) in Company
8th Nov 20075:22 pmRNSHolding(s) in Company
2nd Nov 20073:24 pmRNSHolding(s) in Company
31st Oct 20079:00 amRNSZolpidem on BBC 1 documentary
29th Oct 20077:01 amRNSHolding(s) in Company
26th Oct 20073:58 pmRNSCapital Consolidation, EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.